Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Keytruda
Keytruda
Merck’s Davis Looking to Diversify in Preparation for Keytruda Patent Cliff
BioSpace
Wed, 10/6/21 - 11:23 pm
Merck
Keytruda
patents
patent cliff
cancer
Rob Davis
Oncology the focus for big pharma catalysts
EP Vantage
Tue, 09/28/21 - 11:19 am
Big Pharma
cancer
oncology
Merck
Keytruda
AbbVie
Vraylar
Gilead Sciences
Trodelvy
Sanofi
Sarclisa
Novartis
ligelizumab
Merck touts a confirmatory Keytruda win for liver cancer as 'dangling' accelerated approval saga marches on
Endpoints
Mon, 09/27/21 - 10:48 am
Merck
Keytruda
clinical trials
liver cancer
ESMO21: Libtayo extends survival in first-line NSCLC, challenging Keytruda
Pharmaforum
Mon, 09/20/21 - 11:07 am
Sanofi
Regeneron
Libtayo
ESMO
non-small cell lung cancer
Merck
Keytruda
Merck fleshes out Keytruda win in first-line cervical cancer, adding more firepower to its early cancer push
Endpoints
Sat, 09/18/21 - 08:29 pm
ESMO
Merck
Keytruda
Roche
Avastin
cervical cancer
World Lung 2021 – front-line competition lines up behind Keytruda
EP Vantage
Tue, 09/14/21 - 10:43 am
World Lung
Merck
Keytruda
CStone Pharmaceuticals
Shanghai Junshi Biosciences
lung cancer
Merck Investors Have Reason to Cheer This Label Expansion
Motley Fool
Thu, 09/9/21 - 10:54 am
Merck
Keytruda
Japan
triple negative breast cancer
Merck's Keytruda survives FDA scrutiny in bladder cancer, but ends up with a smaller label
Fierce Pharma
Wed, 09/1/21 - 01:26 pm
Merck
Keytruda
FDA
bladder cancer
The sellside’s most controversial products
EP Vantage
Tue, 08/31/21 - 10:54 am
Merck
Keytruda
Biogen
Aduhelm
Pfizer
Vir Biotechnology
FDA Action Alert: Cara/Vifor, Kadmon, BMS, Merck/Eisai
BioSpace
Mon, 08/23/21 - 11:10 am
FDA
Cara Therapeutics
Vifor Pharma
Korsuva
Kadmon
belumosudil
Bristol Myers Squibb
Opdivo
Merck
Eisai
Keytruda
GSK's Jemperli follows Merck's Keytruda with FDA nod to target certain tumors regardless of location
Fierce Pharma
Wed, 08/18/21 - 11:08 am
GSK
Jemperli
FDA
cancer
Merck
Keytruda
Merck's Best Seller Keytruda Racks Up Another Regulatory Win
BioSpace
Thu, 08/12/21 - 12:35 pm
Merck
Keytruda
advanced renal cell carcinoma
renal cell carcinoma
Eisai
Lemvima
FDA
FDA starts speedy review of Keytruda for adjuvant kidney cancer
Pharmaforum
Wed, 08/11/21 - 10:57 am
Merck
FDA
Keytruda
kidney cancer
Merck's Keytruda takes home adjuvant win in melanoma, escalating early-line fight with Bristol Myers
Endpoints
Thu, 08/5/21 - 11:05 am
Keytruda
Merck
clinical trials
melanoma
Go or no go? August FDA decisions for Axsome, Sanofi and Merck
EP Vantage
Fri, 07/30/21 - 11:04 am
FDA
Axsome Therapeutics
Sanofi
Merck
Pompe disease
depression
kidney cancer
Keytruda
Merck rebounds to win a milestone immunotherapy approval in early breast cancer
BioPharma Dive
Tue, 07/27/21 - 04:39 pm
FDA
Merck
Keytruda
breast cancer
Merck, Eisai notch full approval for Keytruda-TKI inhibitor combo in advanced endometrial cancer
Endpoints
Thu, 07/22/21 - 10:14 pm
Merck
Keytruda
Lenvima
endometrial cancer
FDA
The top 15 blockbuster patent expirations coming this decade
Fierce Pharma
Mon, 07/12/21 - 11:08 am
patents
patent cliff
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Revlimid
Pfizer
Eliquis
Regeneron
Eylea
JNJ
Stelara
Opdivo
GSK
Dolutegravir
Ibrance
Januvia
Eli Lilly
Trulicity
Novo Nordisk
Victoza
Amgen
Prolia
Xgeva
Novartis
Cosentyx
Takeda
Entyvio
FDA Expands Approval for Keytruda in Locally Advanced Cutaneous SCC
BioSpace
Tue, 07/6/21 - 11:18 pm
Merck
Keytruda
cutaneous squamous cell carcinoma
FDA
Merck to withdraw dangling accelerated approval for Keytruda in third-line stomach cancer
Endpoints
Thu, 07/1/21 - 11:09 pm
Merck
Keytruda
oncology
stomach cancer
FDA
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »